Direct-to-Consumer Genetics Testing Market Forecasts to 2028 – Global Analysis By Test Type (Ancestry & Relationship Testing, Carrier Testing, Diabetes Testing and Other Test Types), Services (Diagnostic Screening, New-born Screening, Pre-Implantation Diagnosis and Prenatal), Sample (Saliva, Blood and Urine), Technology (Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis, Whole Genome Sequencing (WGS) and Other Technologies), End User and By Geography
According to Stratistics MRC, the Global Direct-to-Consumer Genetic Testing Market is accounted for $1.48 billion in 2022 and is expected to reach $3.49 billion by 2028 growing at a CAGR of 15.3% during the forecast period. Laboratory tests that can be ordered directly by consumers from their healthcare providers are known as direct-to-consumer tests. After a laboratory has processed the consumer sample, the results are forwarded directly to the customer.
According to MIT Technology Review, the cumulative number of genetic tests conducted in 2019 will exceed 26 million, increasing the demand for automated DNA extraction in the coming years and propelling the market growth.
Market Dynamics
Driver
Easy accessibility and rising chronic diseases
In order to get a trained medical professional's interpretation of the results of a genetic test, patients or healthy individuals must go see that professional. These professionals might be doctors, nurses, or counselors. Since the advent of direct-to-consumer (DTC) genetic testing devices, this procedure has either become unnecessary or voluntary. In addition to making such tests more accessible to potential patients, this has significantly reduced the cost of testing. The rise in chronic diseases like cancer, Alzheimer's, and Parkinson's, as well as rising health awareness, particularly in developed nations like the U.S., Canada, and the U.K., are two major factors driving market expansion.
Restraint
Expensive DTC kits could impede consumer demand
The direct-to-consumer genetic testing market may be hampered by the high costs associated with DTC genetic testing services. In order to introduce high-end DTC tests, many manufacturers are concentrating on product innovations and integrating next-generation technologies, which raises the price of the product. For instance, the price of DTC genetic tests can range from $100 to $3,000, depending on the complexity of the test and the severity of the disease. Because of affordability issues, the demand for genetic services in developing and underdeveloped areas may decline.
Opportunity
Adoption of genomic medicine in developing countries
Uneven distribution of diagnostic laboratories and insufficient funding are issues in developing countries. Accessibility could be greatly improved by using tests that can be administered without laboratory assistance. The lack of durable and affordable test portfolios, as well as their decreased performance as a result of environmental difficulties like high temperatures and dust, are the main causes of the shortage. However, the majority of the key players in the sector believe that these emerging regions are largely untapped, which makes them perfect for business expansion and producing sizable expansion opportunities in the market.
Threat
Friction between manufacturers and regulatory agencies
Manufacturers and regulatory agencies have shown very little cooperation in the market for direct-to-consumer genetic testing devices. For instance, 23andMe was founded in 2006, the business began selling its direct-to-consumer (DTC) genetic testing products in 2007, and Time magazine even named the company's product Invention of the Year in 2008. However, because 23andMe lacked the necessary legal and regulatory approval, the FDA ordered the company to stop marketing its personal genome service (PGS) in 2013. The business vehemently denied the accusation and continued to market its goods until 2015. The business received the FDA's initial approval for genetic tests for 10 diseases in 2017. Market growth is constrained by the friction between manufacturers and regulatory agencies.
Covid-19 Impact
The COVID-19 pandemic boosted telehealth and telemedicine trends, which in turn had a positive impact on the DTC genetic testing market. Patients became more inclined to use online consultation services as a result of the radical transformation of traditional healthcare operations. DTC genetic tests became more popular, enabling patients to understand their genetic profiles without requiring the assistance of a doctor. Patients also adopted digital health alternatives to meet their medical and therapeutic needs as a result of the introduction of strict lockdown restrictions and social distancing norms deployed to stop the spread of the virus. The industry outlook was also bolstered by the rising popularity of e-pharmacies and online drug stores during this COVID-19 pandemic period.
The predictive testing segment is expected to be the largest during the forecast period
Predictive testing dominated the market in 2022 with a 38.0% revenue share and is anticipated to witness the largest market share during the forecast period. Utilizing genomic data to estimate a person's risk of contracting a specific disease or condition is known as predictive genetic testing. Growing demand for personalized medicine and an increase in the frequency of genetic disorders are factors in the segment's expansion. Additionally, it is anticipated that a rising number of product launches will provide a favorable environment for segment growth.
The targeted analysis segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the targeted analysis segment is anticipated to experience profitable growth. Utilizing methods like polymerase chain reaction (PCR), sequencing, or genotyping, targeted analysis examines particular genetic markers. This makes it possible to find genomic variations that could raise someone's risk of getting certain diseases, like cancer, cardiovascular disease, or inherited genomic disorders. This benefit will likely cause the segment to expand over the course of the prediction period.
Region with largest share
In 2022, North America held the largest revenue share (60.1%) in the DTC genetic testing market and is expected to dominate throughout the prediction timeline. The dominance is attributed to a substantial change in consumers' attitudes toward genomic testing. The relatively well-developed healthcare system in North America offers a solid foundation for the expansion of genomic examination services, which further accelerates market growth in the region. Additionally, the increase in spending will further fuel market expansion in this region.
Region with highest CAGR
During the forecast period, Europe is anticipated to have the highest growth rate. The increased focus on early disease detection and prevention, as well as the increased use of genomic examination, among other things, will be the main factors driving market growth in this region. For instance, in order to help Member States address disparities, improve HPV infection screening and vaccination, and support cancer survivors, the European Commission unveiled four new European Union Cancer Plan initiatives in February 2022. Increased vaccination rates are being actively pursued across the continent by several European countries, which is further propelling market expansion.
Key players in the market
Some of the key players profiled in the Direct-to-Consumer Genetic Testing Market include 23andMe, Inc., 24 Genetics, Ancestry, Color Genomics, Inc., Counsyl/Myriad Genetics, Inc. Direct Laboratory Services, LLC, DNA Forensics Laboratory Pvt. Ltd., EasyDNA, Family Tree DNA, Full Genomes Corporation, Inc., Gene by Gene, Ltd., Genesis Healthcare Co., Helix OpCo LLC, Identigene, Interleukin Genetics/orig3n, Karmagenes SA, Laboratory Corporation of America® Holdings, Living DNA Ltd., Mapmygenome, MyHeritage Ltd, Myriad Genetics Inc., OmeCare, Pathway genomics, Positive Bioscience, Inc., Prenetics Limited, Quest Diagnostics, Inc., Request A Test, Ltd., Sonora Quest Laboratories LLC, The SkinDNA Company Pty Ltd, Veritas Genetics and Xcode Life Science.
Key Developments
In July 2022, Genetic Technologies Limited (ASX GTG) is pleased to reveal that it has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA.
In July 2022, 1health.io Inc., an industry-leading software company that enables diagnostic laboratories to expand their testing in the clinical and direct-to-consumer markets quickly and securely, collaborated with Apollo Health Group to bring Apollo's specialized high-performing NGS tests, like pharmacogenetics screenings (PGx) and hereditary cancer genetic screenings (CGx), to the broader clinical market.
Test Types Covered
• Ancestry & Relationship Testing
• Carrier Testing
• Diabetes Testing
• Genetic Health Risk (GHR) Testing
• Nutrigenomic Testing
• Pharmacogenetics testing
• Predictive Testing
• Routine Clinical Testing
• Skincare Testing
• Other Test Types
Services Covered
• Diagnostic Screening
• New-born Screening
• Pre-Implantation Diagnosis
• Prenatal
Samples Covered
• Saliva
• Blood
• Urine
Technologies Covered
• Single Nucleotide Polymorphism (SNP) Chips
• Targeted Analysis
• Whole Genome Sequencing (WGS)
• Other Technologies
Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities,Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Direct-to-Consumer Genetics Testing Market, By Test Type
- 5.1 Introduction
- 5.2 Ancestry & Relationship Testing
- 5.3 Carrier Testing
- 5.4 Diabetes Testing
- 5.5 Genetic Health Risk (GHR) Testing
- 5.6 Nutrigenomic Testing
- 5.7 Pharmacogenetics testing
- 5.8 Predictive Testing
- 5.9 Routine Clinical Testing
- 5.10 Skincare Testing
- 5.11 Other Test Types
- 6 Global Direct-to-Consumer Genetics Testing Market, By Service
- 6.1 Introduction
- 6.2 Diagnostic Screening
- 6.3 New-born Screening
- 6.4 Pre-Implantation Diagnosis
- 6.5 Prenatal
- 7 Global Direct-to-Consumer Genetics Testing Market, By Sample
- 7.1 Introduction
- 7.2 Saliva
- 7.3 Blood
- 7.4 Urine
- 8 Global Direct-to-Consumer Genetics Testing Market, By Technology
- 8.1 Introduction
- 8.2 Single Nucleotide Polymorphism (SNP) Chips
- 8.3 Targeted Analysis
- 8.4 Whole Genome Sequencing (WGS)
- 8.5 Other Technologies
- 9 Global Direct-to-Consumer Genetics Testing Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
- 10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
- 11 Company Profiling
- 11.1 23andMe, Inc.
- 11.2 24 Genetics
- 11.3 Ancestry
- 11.4 Color Genomics, Inc.
- 11.5 Counsyl/Myriad Genetics, Inc.
- 11.6 Direct Laboratory Services, LLC
- 11.7 DNA Forensics Laboratory Pvt. Ltd.
- 11.8 EasyDNA
- 11.9 Family Tree DNA
- 11.10 Full Genomes Corporation, Inc.
- 11.11 Gene by Gene, Ltd.
- 11.12 Genesis Healthcare Co.
- 11.13 Helix OpCo LLC
- 11.14 Identigene
- 11.15 Interleukin Genetics/orig3n
- 11.16 Karmagenes SA
- 11.17 Laboratory Corporation of America® Holdings
- 11.18 Living DNA Ltd.
- 11.19 Mapmygenome
- 11.20 MyHeritage Ltd
- 11.21 Myriad Genetics Inc.
- 11.22 OmeCare
- 11.23 Pathway genomics
- 11.24 Positive Bioscience, Inc.
- 11.25 Prenetics Limited
- 11.26 Quest Diagnostics, Inc.
- 11.27 Request A Test, Ltd.
- 11.28 Sonora Quest Laboratories LLC
- 11.29 The SkinDNA Company Pty Ltd
- 11.30 Veritas Genetics
- 11.31 Xcode Life Sciences
- List of Tables
- Table 1 Global Direct-to-Consumer Genetics Testing Market Outlook, By Region (2020-2028) ($MN)
- Table 2 Global Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
- Table 3 Global Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
- Table 4 Global Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
- Table 5 Global Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
- Table 6 Global Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
- Table 7 Global Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
- Table 8 Global Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
- Table 9 Global Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
- Table 10 Global Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
- Table 11 Global Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
- Table 12 Global Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
- Table 13 Global Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
- Table 14 Global Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
- Table 15 Global Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
- Table 16 Global Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
- Table 17 Global Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
- Table 18 Global Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
- Table 19 Global Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
- Table 20 Global Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
- Table 21 Global Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
- Table 22 Global Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
- Table 23 Global Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
- Table 24 Global Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
- Table 25 Global Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
- Table 26 Global Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 27 North America Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
- Table 28 North America Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
- Table 29 North America Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
- Table 30 North America Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
- Table 31 North America Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
- Table 32 North America Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
- Table 33 North America Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
- Table 34 North America Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
- Table 35 North America Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
- Table 36 North America Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
- Table 37 North America Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
- Table 38 North America Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
- Table 39 North America Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
- Table 40 North America Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
- Table 41 North America Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
- Table 42 North America Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
- Table 43 North America Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
- Table 44 North America Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
- Table 45 North America Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
- Table 46 North America Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
- Table 47 North America Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
- Table 48 North America Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
- Table 49 North America Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
- Table 50 North America Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
- Table 51 North America Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
- Table 52 North America Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 53 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
- Table 54 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
- Table 55 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
- Table 56 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
- Table 57 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
- Table 58 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
- Table 59 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
- Table 60 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
- Table 61 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
- Table 62 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
- Table 63 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
- Table 64 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
- Table 65 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
- Table 66 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
- Table 67 Europe Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
- Table 68 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
- Table 69 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
- Table 70 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
- Table 71 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
- Table 72 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
- Table 73 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
- Table 74 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
- Table 75 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
- Table 76 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
- Table 77 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
- Table 78 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 79 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
- Table 80 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
- Table 81 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
- Table 82 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
- Table 83 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
- Table 84 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
- Table 85 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
- Table 86 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
- Table 87 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
- Table 88 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
- Table 89 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
- Table 90 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
- Table 91 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
- Table 92 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
- Table 93 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
- Table 94 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
- Table 95 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
- Table 96 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
- Table 97 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
- Table 98 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
- Table 99 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
- Table 100 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
- Table 101 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
- Table 102 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
- Table 103 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
- Table 104 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 105 South America Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
- Table 106 South America Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
- Table 107 South America Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
- Table 108 South America Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
- Table 109 South America Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
- Table 110 South America Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
- Table 111 South America Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
- Table 112 South America Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
- Table 113 South America Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
- Table 114 South America Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
- Table 115 South America Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
- Table 116 South America Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
- Table 117 South America Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
- Table 118 South America Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
- Table 119 South America Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
- Table 120 South America Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
- Table 121 South America Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
- Table 122 South America Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
- Table 123 South America Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
- Table 124 South America Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
- Table 125 South America Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
- Table 126 South America Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
- Table 127 South America Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
- Table 128 South America Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
- Table 129 South America Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
- Table 130 South America Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 131 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
- Table 132 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
- Table 133 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
- Table 134 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
- Table 135 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
- Table 136 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
- Table 137 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
- Table 138 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
- Table 139 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
- Table 140 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
- Table 141 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
- Table 142 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
- Table 143 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
- Table 144 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
- Table 145 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
- Table 146 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
- Table 147 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
- Table 148 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
- Table 149 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
- Table 150 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
- Table 151 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
- Table 152 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
- Table 153 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
- Table 154 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
- Table 155 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
- Table 156 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook